SCHEMBL8937171

SCHEMBL8937171

CO[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 7/20 0.72
SMN1; SMN2 Q16637 7/20 0.72
SHBG P04278 6/20 0.72
NR3C1 P04150 5/20 0.72
SERPINA6 P08185 5/20 0.72
MEN1 O00255 4/20 0.72
KMT2A Q03164 4/20 0.72
MAPT P10636 4/20 0.72
CYP2C19 P33261 4/20 0.72
ADORA3 P0DMS8 3/20 0.72
BLM P54132 3/20 0.72
SLC6A3 Q01959 2/20 0.72
MAPK3 P27361 1/20 0.72
HIF1A Q16665 5/20 0.71
CYP3A4 P08684 5/20 0.71
PGR P06401 4/20 0.71
NPSR1 Q6W5P4 3/20 0.71
NR1I2 O75469 2/20 0.71
PDE3A Q14432 2/20 0.71
HPGD P15428 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8853536 0.93 LMNA (0.72) LMNASMN1; SMN2SHBGNR3C1SERPINA6
SCHEMBL11101324 0.92 LMNA (0.71) LMNASMN1; SMN2SHBGNR3C1SERPINA6
SCHEMBL29766827 0.91 SMN1; SMN2 (0.74) LMNASMN1; SMN2SHBGNR3C1SERPINA6
SCHEMBL260024 0.91 SMN1; SMN2 (0.74) LMNASMN1; SMN2SHBGNR3C1SERPINA6
SCHEMBL27048175 0.91 SMN1; SMN2 (0.74) LMNASMN1; SMN2SHBGNR3C1SERPINA6
SCHEMBL11045530 0.91 LMNA (0.69) LMNASMN1; SMN2SHBGNR3C1SERPINA6
SCHEMBL260023 0.91 SMN1; SMN2 (0.74) LMNASMN1; SMN2SHBGNR3C1SERPINA6
SCHEMBL13941349 0.91 SMN1; SMN2 (0.74) LMNASMN1; SMN2SHBGNR3C1SERPINA6
SCHEMBL12666930 0.91 SMN1; SMN2 (0.74) LMNASMN1; SMN2SHBGNR3C1SERPINA6
SCHEMBL10598120 0.91 SHBG (0.67) LMNASMN1; SMN2SHBGNR3C1SERPINA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5506220-A Anti-glaucomatous pharmaceutical composition and the process for obtaining them LABORATOIRE THERAMEX SA (MC) 1996-04-09 US disclosed
US-4102908-A Process for the preparation of pregnane derivatives SCHERING AKTIENGESELLSCHAFT (DE) 1978-07-25 US disclosed